| Serial Advanced Magnetic Resonance Imaging Scan for Guidance of Personalized Adaptive Radiotherapy for High Grade Glioma (NCT04771806) | M.D. Anderson Cancer Center | 2019-04-01 |
| LET Optimized IMPT in Treating Pediatric Patients With Ependymoma (NCT03750513) | M.D. Anderson Cancer Center | 2019-04-01 |
| TK216 and Decitabine in Treating Patients With Relapsed and Refractory Acute Myeloid Leukemia (NCT03752138) | M.D. Anderson Cancer Center | 2019-03-31 |
| Videos and Questionnaires in Assessing Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits (NCT03856060) | M.D. Anderson Cancer Center | 2019-03-30 |
| Open Labeled Placebo in Reducing Cancer Related Fatigue in Patients With Advanced Cancer (NCT03927885) | M.D. Anderson Cancer Center | 2019-03-30 |
| Caregiver Burden, Quality of Life, and Symptom Distress at Different Palliative Cancer Care Settings (NCT04186884) | M.D. Anderson Cancer Center | 2019-03-26 |
| Correlating MicroRNA Changes With Sepsis Outcomes (NCT03929159) | M.D. Anderson Cancer Center | 2019-03-26 |
| Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer (NCT03772834) | M.D. Anderson Cancer Center | 2019-03-25 |
| Web-Based Program in Helping Patients With Head and Neck Cancer Adhere to Swallowing Exercises and Coping Strategies (NCT04003051) | M.D. Anderson Cancer Center | 2019-03-18 |
| Nutritional Supplementation in Reducing Complications in Patients With Locally Advanced Esophageal Cancer Undergoing Chemotherapy, Radiation Therapy, and/or Surgery (NCT04029857) | M.D. Anderson Cancer Center | 2019-03-14 |
| TAK-659 and Paclitaxel in Treating Patients With Advanced Solid Tumors (NCT03756818) | M.D. Anderson Cancer Center | 2019-03-05 |
| Repeat Quadratus Lumborum Block to Reduce Opioid Need in Patients After Pancreatic Surgery (NCT03745794) | M.D. Anderson Cancer Center | 2019-02-28 |
| MOM's PAIN (Methylene Blue for Oral Mucositis' PAIN) (NCT03469284) | M.D. Anderson Cancer Center | 2019-02-28 |
| Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (NCT03862157) | M.D. Anderson Cancer Center | 2019-02-27 |
| Low Dose Ipilimumab With Pembrolizumab in Treating Patients With Melanoma That Has Spread to the Brain (NCT03873818) | M.D. Anderson Cancer Center | 2019-02-21 |
| Phase I/II Study of Perioperative Chemotherapy Plus Immunotherapy Followed by Surgery in Localized Esophageal and Gastroesophageal Adenocarcinoma (NCT03784326) | M.D. Anderson Cancer Center | 2019-02-19 |
| Nivolumab and Ibrutinib in Treating Patients With Relapsed or Refractory Central Nervous System Lymphoma (NCT03770416) | M.D. Anderson Cancer Center | 2019-02-15 |
| MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma (NCT03896568) | M.D. Anderson Cancer Center | 2019-02-12 |
| Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Patients With Prostate Cancer (NCT03581500) | M.D. Anderson Cancer Center | 2019-02-06 |
| Ultra Low-Dose Radiation Therapy in Treating Patients With Stage I-IV Stomach MALT Lymphoma (NCT03680586) | M.D. Anderson Cancer Center | 2019-02-04 |
| Hu8F4 in Treating Patients With Advanced Hematologic Malignancies (NCT02530034) | M.D. Anderson Cancer Center | 2019-01-31 |
| Circulating Cell-Free Tumor DNA Testing in Guiding Treatment for Patients With Advanced or Metastatic Colorectal Cancer (NCT03844620) | M.D. Anderson Cancer Center | 2019-01-29 |
| Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory Osteosarcoma (NCT03598595) | M.D. Anderson Cancer Center | 2019-01-28 |
| Venetoclax and Quizartinib in Treating Patients With FLT3-mutated Recurrent or Refractory Acute Myeloid Leukemia (NCT03735875) | M.D. Anderson Cancer Center | 2019-01-25 |
| Single-arm Study With Bimiralisib in Patients With HNSCC Harboring NOTCH1 Loss of Function Mutations (NCT03740100) | M.D. Anderson Cancer Center | 2019-01-25 |
| Clinical Data Collection in Studying Clinical Factors Associated With Post-Surgery Chronic Opioid Use in Patients With Head and Neck Cancers (NCT03888651) | M.D. Anderson Cancer Center | 2019-01-25 |
| ALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid Tumors (NCT03725436) | M.D. Anderson Cancer Center | 2019-01-24 |
| Parent and Family Oriented Support Interventions for the Facilitation of Weight Loss in African American Families (NCT04644224) | M.D. Anderson Cancer Center | 2019-01-17 |
| Daratumumab, Bortezomib, and Dexamethasone Followed by Daratumumab, Ixazomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT03763162) | M.D. Anderson Cancer Center | 2019-01-17 |
| Feasibility of Laryngeal Mask Airway Gastro on Patients Undergoing Endoscopic Retrograde Cholangiopancreatography for Pancreas and Bile Duct Disorders (NCT03775681) | M.D. Anderson Cancer Center | 2019-01-16 |
| Flexible Intubation Scope With or Without Video Laryngoscope in Supporting Endotracheal Tube Placement in Patients With Head and Neck Cancer Before Surgery (NCT03757091) | M.D. Anderson Cancer Center | 2019-01-15 |
| Gallium Ga 68-DOTATATE PET/CT in Predicting Tumor Growth in Patients With Meningiomas (NCT03953131) | M.D. Anderson Cancer Center | 2019-01-10 |
| Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer (NCT03776487) | M.D. Anderson Cancer Center | 2019-01-07 |
| Correlation of Genomic Variation in Enzymes Responsible for Metabolism of Capecitabine With Drug Metabolism (NCT00960544) | M.D. Anderson Cancer Center | 2019-01-01 |
| PD 0360324 and Cyclophosphamide in Treating Patients With Recurrent High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (NCT02948101) | M.D. Anderson Cancer Center | 2018-12-31 |
| Personalized Vaccine in Treating Patients With Smoldering Multiple Myeloma (NCT03631043) | M.D. Anderson Cancer Center | 2018-12-21 |
| Patient-Derived Xenografts in Personalizing Treatment for Patients With Relapsed/Refractory Mantle Cell Lymphoma (NCT03219047) | M.D. Anderson Cancer Center | 2018-12-20 |
| Assessment of Functional and Symptom Outcomes for Survivors of Paranasal Sinus, Nasopharyngeal and Skull Base Tumors (NCT05733091) | M.D. Anderson Cancer Center | 2018-12-20 |
| Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers (NCT03948100) | M.D. Anderson Cancer Center | 2018-12-20 |
| Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF (NCT03604315) | M.D. Anderson Cancer Center | 2018-12-18 |
| Local Consolidative Therapy and Brigatinib in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer (NCT03707938) | M.D. Anderson Cancer Center | 2018-12-18 |
| Shorter Course, Hypofractionated Pre-Surgery Radiation Therapy in Treating Patients With Localized, Resectable Soft Tissue Sarcoma of the Extremity of Superficial Trunk (NCT03819985) | M.D. Anderson Cancer Center | 2018-12-17 |
| Milademetan Tosylate and Low-Dose Cytarabine With or Without Venetoclax in Treating Participants With Recurrent or Refractory Acute Myeloid Leukemia (NCT03634228) | M.D. Anderson Cancer Center | 2018-12-17 |
| Health Literacy and Smoking Cessation in Low-SES Diverse Smokers - Project HALT II (NCT02942212) | M.D. Anderson Cancer Center | 2018-12-14 |
| Effectiveness of an Online Intervention Targeting Cancer-related Fatigue (NCT03809130) | M.D. Anderson Cancer Center | 2018-12-10 |
| GRAvity- Versus Wall Suction-drIven Large Volume Thoracentesis: a RAndomized Controlled Study (GRAWITAS Study) (NCT05131945) | M.D. Anderson Cancer Center | 2018-12-10 |
| Quit4Health Intervention in Supporting Smoking Cessation and Preventing Smoking Initiation in Young Adults (NCT04009590) | M.D. Anderson Cancer Center | 2018-12-10 |
| Adavosertib With or Without Olaparib in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (NCT03579316) | M.D. Anderson Cancer Center | 2018-12-07 |
| 18F-FDG PET-MRI for Planning and Follow-Up of Patients With Spine Tumors Treated With Spine Stereotactic Radiosurgery (NCT05174026) | M.D. Anderson Cancer Center | 2018-11-30 |
| Cognitive Behavioral Therapy in Helping Patients With Acute Myeloid Leukemia or Lymphoma With Cancer-Related Fatigue (NCT03747757) | M.D. Anderson Cancer Center | 2018-11-29 |
| Levorphanol as a Second Line Opioid in Reducing Pain in Patients With Cancer (NCT03579446) | M.D. Anderson Cancer Center | 2018-11-29 |
| Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer (NCT03637816) | M.D. Anderson Cancer Center | 2018-11-27 |
| Online Psychosocial Intervention in Improving Social Well-Being and Support in Women With Stage I-IV Non-small Cell Lung Cancer Undergoing Treatment (NCT03731585) | M.D. Anderson Cancer Center | 2018-11-15 |
| DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine INO-3112 and Durvalumab in Treating Patients With Recurrent or Metastatic Human Papillomavirus Associated Cancers (NCT03439085) | M.D. Anderson Cancer Center | 2018-11-14 |
| Pembrolizumab in Preventing Lung Cancer in Patients With Stage I-II Non-Small Cell Lung Cancer or High-Risk Pulmonary Nodules, the IMPRINT-Lung Study (NCT03634241) | M.D. Anderson Cancer Center | 2018-11-13 |
| Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility Trial (NCT03690921) | M.D. Anderson Cancer Center | 2018-11-08 |
| Pre-operative SRS or Post-operative SRS in Treating Cancer Patients With Brain Metastases (NCT03741673) | M.D. Anderson Cancer Center | 2018-11-08 |
| Liposome-encapsulated Daunorubicin-Cytarabine and Gemtuzumab Ozogamicin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (NCT03672539) | M.D. Anderson Cancer Center | 2018-11-07 |
| Recombinant Human Interleukin-7 (CYT107) to Promote T-Cell Recovery After Cord Blood Transplantation (NCT03600896) | M.D. Anderson Cancer Center | 2018-11-01 |
| Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome (NCT03661307) | M.D. Anderson Cancer Center | 2018-10-31 |
| Liposome-encapsulated Daunorubicin-Cytarabine and Venetoclax in Treating Participants With Relapsed, Refractory or Untreated Acute Myeloid Leukemia (NCT03629171) | M.D. Anderson Cancer Center | 2018-10-29 |
| Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia (NCT03586609) | M.D. Anderson Cancer Center | 2018-10-25 |
| Arginine in Treating Patients With Anti-VEGF Induced Kidney Injury (NCT02882373) | M.D. Anderson Cancer Center | 2018-10-23 |
| Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Colorectal Cancer, or Pancreatic Ductal Adenocarcinoma (NCT03610490) | M.D. Anderson Cancer Center | 2018-10-16 |
| Nivolumab and Ipilimumab After Donor Stem Cell Transplant in Treating Patients With High Risk Refractory or Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT03600155) | M.D. Anderson Cancer Center | 2018-10-11 |
| Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy (NCT03630991) | M.D. Anderson Cancer Center | 2018-10-11 |
| Preference of Room Setting and Waiting Time in Patients With Advanced, Locally Advanced, or Metastatic Cancer and Their Caregivers Who Are Seen in the Outpatient Supportive/Palliative Care Center (NCT03671226) | M.D. Anderson Cancer Center | 2018-09-28 |
| Meditative Slow Breathing or Isha Kriya Meditation in Improving Cancer-Related Symptoms in Hospitalized Participants With Cancer (NCT03445572) | M.D. Anderson Cancer Center | 2018-09-21 |
| Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal Carcinomatosis (NCT03508570) | M.D. Anderson Cancer Center | 2018-09-21 |
| FDG PET-MRI for the Diagnosis of Spinal Cord Lesions (NCT04219969) | M.D. Anderson Cancer Center | 2018-09-21 |
| Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers (NCT03589729) | M.D. Anderson Cancer Center | 2018-09-19 |
| Bronchoscopic Laser Ablation of Peripheral Lung Tumors (NCT03707925) | M.D. Anderson Cancer Center | 2018-09-18 |
| Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation (NCT03683433) | M.D. Anderson Cancer Center | 2018-09-18 |
| Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors (NCT04265430) | M.D. Anderson Cancer Center | 2018-09-17 |
| Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With Advanced or Recurrent Sarcoma (NCT03450122) | M.D. Anderson Cancer Center | 2018-09-13 |
| Self-Hypnosis for the Enhanced Recovery After Surgery in Patients With Gynecologic Cancer (NCT04266886) | M.D. Anderson Cancer Center | 2018-09-11 |
| PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer (NCT04219904) | M.D. Anderson Cancer Center | 2018-09-07 |
| T-Cell Infusion, Aldesleukin, and Utomilumab in Treating Patients With Recurrent Ovarian Cancer (NCT03318900) | M.D. Anderson Cancer Center | 2018-09-04 |
| Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors (NCT03420963) | M.D. Anderson Cancer Center | 2018-08-31 |
| Survey of Post-Acute Inpatient Rehabilitation Safety Concerns in Participants With Cancer (NCT03656224) | M.D. Anderson Cancer Center | 2018-08-29 |
| DECT in Imaging Patients With Solid Organ Cancer With Intracranial Metastasis (NCT03685539) | M.D. Anderson Cancer Center | 2018-08-24 |
| ADCT-602 in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic Leukemia (NCT03698552) | M.D. Anderson Cancer Center | 2018-08-24 |
| Navigated Repetitive Transcranial Magnetic Stimulation in Improving Motor Rehabilitation in Participants With Brain Tumors (NCT03606161) | M.D. Anderson Cancer Center | 2018-08-23 |
| Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence (NCT03583710) | M.D. Anderson Cancer Center | 2018-08-20 |
| Hydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Positive, HER2 Negative Breast Cancer (NCT03774472) | M.D. Anderson Cancer Center | 2018-08-20 |
| Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer (NCT03587662) | M.D. Anderson Cancer Center | 2018-08-17 |
| Electronic Neurocognitive Tools in Screening for Mental Capability in Patients Undergoing Liver Surgery (NCT03678441) | M.D. Anderson Cancer Center | 2018-08-17 |
| Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma (NCT03941756) | M.D. Anderson Cancer Center | 2018-08-14 |
| Tinostamustine With or Without Radiation Therapy in Treating Patients With Newly Diagnosed MGMT-Unmethylated Glioblastoma (NCT03452930) | M.D. Anderson Cancer Center | 2018-08-13 |
| Tailored Smoking Cessation Intervention in Promoting Sexual and Gender Minority Smokers to Quit Smoking (NCT03669120) | M.D. Anderson Cancer Center | 2018-08-10 |
| Rectal Administration of Opioids Using the Macy Catheter in Reducing Pain in Patients With Advanced Cancer (NCT03592459) | M.D. Anderson Cancer Center | 2018-08-08 |
| Manual Therapy in Treating Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors (NCT03612531) | M.D. Anderson Cancer Center | 2018-08-06 |
| MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer (NCT03634267) | M.D. Anderson Cancer Center | 2018-08-03 |
| Dual Time Point FDG PET/MRI Scan in Improving the Imaging Cancer Patients With Brain Metastases (NCT05054998) | M.D. Anderson Cancer Center | 2018-08-03 |
| M7824 in Treating Patients With Stage II-III HER2 Positive Breast Cancer (NCT03620201) | M.D. Anderson Cancer Center | 2018-08-03 |
| A Study of Cancer Related Fatigue in Patients With Metastatic Cancer Receiving Anti-PD1 Immunotherapy (NCT03525873) | M.D. Anderson Cancer Center | 2018-08-02 |
| Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in Children (NCT03111069) | M.D. Anderson Cancer Center | 2018-08-01 |
| Chronic Non-Malignant Pain in Cancer Patients at a Supportive Care Clinic (NCT03043378) | M.D. Anderson Cancer Center | 2018-07-31 |
| Systemic Therapy With or Without Local Consolidative Therapy in Treating Patients With Oligometastatic Solid Tumor (NCT03599765) | M.D. Anderson Cancer Center | 2018-07-31 |
| CT Perfusion Scans in Detecting Changes in Blood Flow to the Liver After Portal Vein Embolization (NCT03990623) | M.D. Anderson Cancer Center | 2018-07-21 |